Brain zap trial aims to restore thinking and balance in rare syndrome
NCT ID NCT07166432
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 31 times
Summary
This study tests a new, minimally invasive brain stimulation technique for people with cerebellar cognitive affective syndrome (CCAS) caused by Cushing's syndrome. The treatment uses a device placed near the cerebellum to improve both thinking and movement. The trial will enroll 200 participants and measure changes in ataxia and cognitive scores after 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBELLAR ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Urology, Peking University First Hospital, Beijing, 100034
RECRUITINGBeijing, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.